Clinical Trial NCT06932744

Trial

Wuhan MY008211A-PNH-3-02 (NCT06932744)

Clinical trial ID

NCT06932744

Drug name

MY008211A

Company:

Wuhan Createrna Science and Technology Co., Ltd

Drug trade name

Eculizumab Injection

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Recruiting

Start

08/2024

Substance

Research question

Delivery method of drug

Frequency

Clinical trial locations

China